To directly test whether NRF2 triggers the tumor-promoting action of malignant senescent cells, we used a knockdown approach, introducing a microRNA targeting NRF2 (miR-NRF2) into the lentivirus used to induce gliomagenesis. The gene discussed is NFE2L2; the disease is neoplasm.